Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FHA40
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,075
Award facts
- Contract value 100% obligated
- $47,074.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $47,074.84 to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 mL vials. This firm fixed-price contract, issued on May 16, 2025, with an ultimate completion date of May 19, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and functions as a global pharmaceutical support vehicle. The contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and the U.S. Coast Guard. The DLA Troop Support Medical program reflects the agency's strategic approach to pharmaceutical procurement through prime vendor arrangements that provide flexible access to essential medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FHA40?
SPE2DB25FHA40 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 16, 2025.
How much is contract SPE2DB25FHA40 worth?
The government has obligated $47,075 on SPE2DB25FHA40.
Is contract SPE2DB25FHA40 an order under another contract?
Yes. SPE2DB25FHA40 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHA40 competed?
The extent of competition for SPE2DB25FHA40 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award